• Country
    Clear
  • Thematic
    Clear
  • Type
  • Compatibility Level
  • Jurisdiction
2,090 Data sources

  • NL
  • CA
  • DZ
  • Thematic: No

  • more_vert
  • University of Groningen institutional repository

    more_vert
  • Nearly 60% of patients undergoing cancer treatment are estimated to have had at least one potential drug-drug interaction; for patients receiving oral anticancer therapy, up to 50% have been reported to experience a potential drug-drug interaction, with 16% experiencing a major event. Drug-drug interactions are therefore a significant issue for cancer patients and the health care professionals who treat them. Combining the internationally recognised drug-drug interactions expertise of the University of Liverpool (UK) with the clinical pharmacology in oncology and haemotology expertise of Radboud University, Nijmegen (the Netherlands), this site was established in 2017 in response to the need for improved management of DDIs with anti-cancer agents.

    more_vert
  • more_vert
  • more_vert
  • Online storage, sharing and registration of research data, during the research period and after its completion. DataverseNL is a shared service provided by participating institutions and DANS.

    more_vert
  • more_vert
  • This site is a university repository providing access to the publication output of the institution. Extensive information on the advisory and editorial boards that support this sites content and strategic development is included.

    more_vert
  • more_vert
  • more_vert
  • chevron_left
  • 2
  • 3
  • 4
  • 5
  • 6
  • chevron_right
2,090 Data sources
  • more_vert
  • University of Groningen institutional repository

    more_vert
  • Nearly 60% of patients undergoing cancer treatment are estimated to have had at least one potential drug-drug interaction; for patients receiving oral anticancer therapy, up to 50% have been reported to experience a potential drug-drug interaction, with 16% experiencing a major event. Drug-drug interactions are therefore a significant issue for cancer patients and the health care professionals who treat them. Combining the internationally recognised drug-drug interactions expertise of the University of Liverpool (UK) with the clinical pharmacology in oncology and haemotology expertise of Radboud University, Nijmegen (the Netherlands), this site was established in 2017 in response to the need for improved management of DDIs with anti-cancer agents.

    more_vert
  • more_vert
  • more_vert
  • Online storage, sharing and registration of research data, during the research period and after its completion. DataverseNL is a shared service provided by participating institutions and DANS.

    more_vert
  • more_vert
  • This site is a university repository providing access to the publication output of the institution. Extensive information on the advisory and editorial boards that support this sites content and strategic development is included.

    more_vert
  • more_vert
  • more_vert
  • chevron_left
  • 2
  • 3
  • 4
  • 5
  • 6
  • chevron_right